These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2474516)

  • 41. Production and characterization of monoclonal antibodies against carcinoembryonic antigen (CEA).
    Jantscheff P; Böttger V; Price M; Micheel B; Kaiser G; Zotter S; Kotzsch M; Grossmann H; Karsten U
    Biomed Biochim Acta; 1991; 50(12):1261-7. PubMed ID: 1824544
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of second-generation monoclonal antibodies against carcinoembryonic antigen.
    Hansen HJ; Goldenberg DM; Newman ES; Grebenau R; Sharkey RM
    Cancer; 1993 Jun; 71(11):3478-85. PubMed ID: 7683969
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential reactivities of carcinoembryonic antigen (CEA) and CEA-related monoclonal and polyclonal antibodies in common epithelial malignancies.
    Sheahan K; O'Brien MJ; Burke B; Dervan PA; O'Keane JC; Gottlieb LS; Zamcheck N
    Am J Clin Pathol; 1990 Aug; 94(2):157-64. PubMed ID: 1695478
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Monoclonal antibodies for carcinoembryonic antigen and related antigens as a model system: determination of affinities and specificities of monoclonal antibodies by using biotin-labeled antibodies and avidin as precipitating agent in a solution phase immunoassay.
    Wagener C; Clark BR; Rickard KJ; Shively JE
    J Immunol; 1983 May; 130(5):2302-7. PubMed ID: 6187848
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epitopes of carcinoembryonic antigen defined by monoclonal antibodies prepared from mice immunized with purified carcinoembryonic antigen or HCT-8R cells.
    Haggarty A; Legler C; Krantz MJ; Fuks A
    Cancer Res; 1986 Jan; 46(1):300-9. PubMed ID: 2415248
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Monoclonal antibody COL-1 reacts with restricted epitopes on carcinoembryonic antigen: an immunohistochemical study.
    Shi ZR; Tacha D; Itzkowitz SH
    J Histochem Cytochem; 1994 Sep; 42(9):1215-9. PubMed ID: 7520463
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Specificity and affinity of monoclonal antibodies against carcinoembryonic antigen.
    Nap M; Hammarström ML; Börmer O; Hammarström S; Wagener C; Handt S; Schreyer M; Mach JP; Buchegger F; von Kleist S
    Cancer Res; 1992 Apr; 52(8):2329-39. PubMed ID: 1559235
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Purification and characterization of a 50,000 mol. wt glycoprotein antigen, and localization of determinants involved in cross-reactivity with carcinoembryonic antigen.
    Laferté S; Krantz MJ
    Mol Immunol; 1983 Apr; 20(4):421-31. PubMed ID: 6191208
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of a novel tumor-associated Mr 110,000 gene product in human gastric carcinoma cells that is immunologically related to carcinoembryonic antigen.
    Shimada S; Ogawa M; Schlom J; Greiner JW
    Cancer Res; 1991 Oct; 51(20):5694-703. PubMed ID: 1913687
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reaction profiles of seven enzyme immunoassay kits for carcinoembryonic antigen (CEA) analyzed with purified preparations of CEA and related normal antigens.
    Kuroki M; Haruno M; Arakawa F; Wakisaka M; Matsuoka Y
    Clin Biochem; 1992 Feb; 25(1):29-35. PubMed ID: 1551238
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preparation and characterization of monoclonal antibodies specific to synthetic peptide of carcinoembryonic antigen.
    Tsujisaki M; Imai K; Hishikawa N; Tokuchi S; Hinoda Y; Matsukawa H; Oikawa S; Nakazato H; Yachi A
    Int J Cancer; 1991 Jan; 47(2):267-73. PubMed ID: 1703128
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A reference of the GOLD classification of monoclonal antibodies against carcinoembryonic antigen to the domain structure of the carcinoembryonic antigen molecule.
    Murakami M; Kuroki M; Arakawa F; Kuwahara M; Oikawa S; Nakazato H; Matsuoka Y
    Hybridoma; 1995 Feb; 14(1):19-28. PubMed ID: 7768530
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunochemical differences among carcinoembryonic antigen in tumor tissues and related antigens in meconium and adult feces.
    Matsuoka Y; Kuroki M; Koga Y; Kuriyama H; Mori T; Kosaki G
    Cancer Res; 1982 May; 42(5):2012-8. PubMed ID: 6175402
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of monoclonal antibodies to carcinoembryonic antigen with increased tumor specificity.
    Jothy S; Brazinsky SA; Chin-A-Loy M; Haggarty A; Krantz MJ; Cheung M; Fuks A
    Lab Invest; 1986 Jan; 54(1):108-17. PubMed ID: 2417036
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunological heterogeneity of carcinoembryonic antigen: immunohistochemical detection of carcinoembryonic antigen determinants in colonic tumors with monoclonal antibodies.
    Primus FJ; Kuhns WJ; Goldenberg DM
    Cancer Res; 1983 Feb; 43(2):693-701. PubMed ID: 6184153
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Binding of five monoclonal anti-CEA antibodies with different epitope specificities to various carcinoma tissues.
    Wagener C; Petzold P; Köhler W; Totović V
    Int J Cancer; 1984 Apr; 33(4):469-75. PubMed ID: 6200447
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Therapeutic efficacy of a high-affinity anticarcinoembryonic antigen monoclonal antibody (COL-1).
    Siler K; Eggensperger D; Hand PH; Milenic DE; Miller LS; Houchens DP; Hinkle G; Schlom J
    Biotechnol Ther; 1993; 4(3-4):163-81. PubMed ID: 8292968
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proteolytic release of antigenic fragments corresponding to normal fecal antigen and non-specific cross-reacting antigen from carcinoembryonic antigen.
    Matsuoka Y; Koga Y; Maruta H; Yoshino M; Tsuru E
    Int J Cancer; 1978 May; 21(5):604-10. PubMed ID: 77849
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Detection of carcinoembryonic antigen in colonic effluent by specific anti-CEA monoclonal antibodies.
    Tobi M; O'Kieffe D; Trujillo N; Nochomovitz LE; Steinberg WM
    Cancer Lett; 1992 Oct; 67(1):47-54. PubMed ID: 1423244
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Determination of the specificities of monoclonal antibodies recognizing members of the CEA family using a panel of transfectants.
    Daniel S; Nagel G; Johnson JP; Lobo FM; Hirn M; Jantscheff P; Kuroki M; von Kleist S; Grunert F
    Int J Cancer; 1993 Sep; 55(2):303-10. PubMed ID: 7690348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.